Cord Blood. Investieren in die Zukunft von Morgen.

so schnell wie es nach oben geht....so schnell geht es wieder runter...Wetten???

Wenn die Firma ihre Einkünfte steigern kann und die Kosten der Expansion bezahlt sind,wird sich der Kurs in anderen Regionen wieder finden.Interessante Beiträge dazu auf I-Hub.GLTA

Resplit tat sehr weh.

Ja,das auf jeden Fall,dazu kommen auch noch viele die in2008-2010 eingestiegen waren,da brauchst dann schon richtig Geld um deinen EK Durchschnitt zu senken.Die Gewissheit,dann gut aus der Sache raus zu kommen hat man ja auch nicht.

bei mir war es auch so...habe kein Vertrauen mehr zu dieser Aktie.Vieles ist sehr unklar....

ih.advfn.com/...riod=0&drawmode=0&size=19&volume=1

Warum verschwindest  Du nicht in Deine Gentakrabbelgruppe nd gehst einem hier nicht auf den Sack.

Sie sind aktuell.www.smallcapnetwork.com/...ia/7474/article/view/p/mid/1/id/12/ Ich denke wir haben noch schöne Tage vor uns!

gesagt...es geht nach unten..bitte schoen.Und das war noch nicht alles.Manche verdienen sich eine goldene Nase.

Aber wenn Moses warnt dann hat das meistens Hand und Fuß.
Außerdem gab es Gestern ein "Shoorting Star".
Der kurze sehr schnelle Anstieg ist auch ein Warnzeichen. Danach geht es meist auch
wieder sehr schnell abwärts. Jedenfalls meine Erfahrung.

das ist auch meine Meinung.Aber es geben leider zu viele Trauemer....die schnell reich werden wollen.Wer nicht?Ich auch.Aber man muss gut aufpassen was man macht.Gruesse DB

 

In the news release, Cord Blood America Says Nine Month Revenues Up 59 Percent to $4.38 Million, issued 14-Nov-2011 by Cord Blood America, Inc. over PR Newswire, we are advised by the company that the fourth paragraph should read as stated below rather than as originally issued inadvertently. The complete, corrected release follows:

Cord Blood America Says Nine Month Revenues Up 59 Percent to $4.38 Million

-- Gross Profit Up 91 Percent --

www.finanznachrichten.de/...o-n-cord-blood-america-inc-008.htm

investorshub.advfn.com/boards/read_msg.aspx?message_id=69039443

finance.yahoo.com/news/...s-prnews-3613119575.html?x=0&l=1

0.06210.0141 (29.38%)
Real-Time Best Bid & Ask
0.063 / 0.065 (1 x 1)Why is size 1?
Previous Close 0.048 Open 0.052
Daily Range 0.067 - 0.05 52wk Range 0.55 - 0.015
Volume 2,719,642 Dividend N/A
Average Vol (3m) 1,340,042 Yield N/A

de.advfn.com/...ticchart&s=CBAI&p=0&t=37&vol=1

 

investorshub.advfn.com/boards/read_msg.aspx?message_id=69132618

TAMPA, Fla., Nov. 21, 2011 /PRNewswire/ -- Comprehensive Care Corporation ("CompCare") (OTC BB: CHCR), a leading behavioral health, substance abuse and psychotropic pharmacy management services provider for managed care companies throughout the U.S., is pleased to announce that its revenues for the nine months ended September 30, 2011 increased 212 percent to $54,039,000 compared to $17,344,000 for the same period in 2010.

Revenues for the three months ended September 30, 2011 totaled $17,200,000, up 118 percent compared to revenues of $7,901,000 in the same period in 2010.

"We are delighted by this significant increase in revenues," said Clark Marcus, CompCare's Chairman and Chief Executive Officer.  "A year ago, the Company's revenues for the nine-month period ended September 30, 2010 were up 66% from the same nine-month period in 2009.  The entire two-year period of 2009 to 2011 represented a material transition and growth time for the Company during which the Company not only maintained full staff but added significant executive personnel in order to position the Company for profitability.  By successfully increasing the Company's business and adding top-line revenue, we believe the Company is on the track to achieve sustainable profitability in 2012, and we look forward to continuing to announce this progress to our investors."  The entire 10-Q filing is available at www.sec.gov.

CompCare's revenues are obtained through managed care activities, the majority of which are performed under the terms of at-risk agreements with health maintenance organizations and other health plans or payers to provide contracted behavioral healthcare services to subscribing participants. Revenue under a substantial portion of these agreements is earned monthly based on the number of qualified participants regardless of services actually provided.  This is generally referred to as at-risk arrangements.  

Under certain behavioral health contracts CompCare also manages the psychotropic drug benefit for the health plan's subscribing participants and is responsible for the cost of drugs dispensed.  Pharmacy drug management revenue is recognized monthly at a contracted rate per eligible member.  In accordance with the contracts, the health plan's pharmacy benefit manager performs drug price negotiation and claims adjudication.

translate.google.de/translate

translate.google.de/translate

Bin nicht mehr auf dem Laufenden bei CBAI, also wer weiß was diese Nachricht verbirgt.

Cord Blood America kündigt DTCC Entfernt "Chill" im Dezember 2010 Imposed

translate.googleusercontent.com/translate_c

ih.advfn.com/p.php

investorshub.advfn.com/boards/board.aspx

Cord Blood America CEO Matthew Schissler Interviewed On 2011 Financial Performance, Stock Price, 2012 Strategies

www.finanznachrichten.de/...tock-price-2012-strategies-008.htm